BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 27216769)

  • 1. Quantification of 2-methylcitric acid in dried blood spots improves newborn screening for propionic and methylmalonic acidemias.
    Al-Dirbashi OY; McIntosh N; Chakraborty P
    J Med Screen; 2017 Jun; 24(2):58-61. PubMed ID: 27216769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders.
    Monostori P; Klinke G; Richter S; Baráth Á; Fingerhut R; Baumgartner MR; Kölker S; Hoffmann GF; Gramer G; Okun JG
    PLoS One; 2017; 12(9):e0184897. PubMed ID: 28915261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of methylmalonic acid, 2-methylcitric acid, and total homocysteine in dried blood spots by liquid chromatography-tandem mass spectrometry: A reliable follow-up method for propionylcarnitine-related disorders in newborn screening.
    Hu Z; Yang J; Lin Y; Wang J; Hu L; Zhang C; Zhang Y; Huang X
    J Med Screen; 2021 Jun; 28(2):93-99. PubMed ID: 32615850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry.
    la Marca G; Malvagia S; Pasquini E; Innocenti M; Donati MA; Zammarchi E
    Clin Chem; 2007 Jul; 53(7):1364-9. PubMed ID: 17510301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.
    Malvagia S; Haynes CA; Grisotto L; Ombrone D; Funghini S; Moretti E; McGreevy KS; Biggeri A; Guerrini R; Yahyaoui R; Garg U; Seeterlin M; Chace D; De Jesus VR; la Marca G
    Clin Chim Acta; 2015 Oct; 450():342-8. PubMed ID: 26368264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma methylcitric acid and its correlations with other disease biomarkers: The impact in the follow up of patients with propionic and methylmalonic acidemia.
    Maines E; Catesini G; Boenzi S; Mosca A; Candusso M; Dello Strologo L; Martinelli D; Maiorana A; Liguori A; Olivieri G; Taurisano R; Piemonte F; Rizzo C; Spada M; Dionisi-Vici C
    J Inherit Metab Dis; 2020 Nov; 43(6):1173-1185. PubMed ID: 32681732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of propionylcarnitine in blood and methylmalonic acid in urine of 162 patients with methylmalonic acidemia].
    Wu SN; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):561-5. PubMed ID: 23663331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of total homocysteine, methylmalonic acid, and 2-methylcitric acid in dried blood spots by tandem mass spectrometry.
    Turgeon CT; Magera MJ; Cuthbert CD; Loken PR; Gavrilov DK; Tortorelli S; Raymond KM; Oglesbee D; Rinaldo P; Matern D
    Clin Chem; 2010 Nov; 56(11):1686-95. PubMed ID: 20807894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A False-Positive Case of Methylmalonic Aciduria by Tandem Mass Spectrometry Newborn Screening Dependent on Maternal Malnutrition in Pregnancy.
    Rossi C; Cicalini I; Rizzo C; Zucchelli M; Consalvo A; Valentinuzzi S; Semeraro D; Gasparroni G; Brindisino P; Gazzolo D; Dionisi-Vici C; De Laurenzi V; Pieragostino D
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32443888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 2-methylcitric acid, methylmalonic acid, and total homocysteine in dried blood spots by LC-MS/MS for application in the newborn screening laboratory: A dual derivatization approach.
    Dubland JA; Rakić B; Vallance H; Sinclair G
    J Mass Spectrom Adv Clin Lab; 2021 Apr; 20():1-10. PubMed ID: 34820666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Challenges Using a 2-Tier Strategy for Methylmalonic Acidurias: Data from 1.2 Million Dried Blood Spots.
    Weiss KJ; Röschinger W; Blessing H; Lotz-Havla AS; Schiergens KA; Maier EM
    Ann Nutr Metab; 2020; 76(4):268-276. PubMed ID: 32683363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria.
    Shigematsu Y; Hata I; Tajima G
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S283-8. PubMed ID: 20440648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotope dilution analysis of methylcitric acid in amniotic fluid for the prenatal diagnosis of propionic and methylmalonic acidemia.
    Naylor G; Sweetman L; Nyhan WL; Hornbeck C; Griffiths J; Mörch L; Brandänge S
    Clin Chim Acta; 1980 Nov; 107(3):175-83. PubMed ID: 7002368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.
    Weisfeld-Adams JD; Morrissey MA; Kirmse BM; Salveson BR; Wasserstein MP; McGuire PJ; Sunny S; Cohen-Pfeffer JL; Yu C; Caggana M; Diaz GA
    Mol Genet Metab; 2010 Feb; 99(2):116-23. PubMed ID: 19836982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening for propionic, methylmalonic acidemia and vitamin B12 deficiency. Analysis of 588,793 newborns.
    Martín-Rivada Á; Cambra Conejero A; Martín-Hernández E; Moráis López A; Bélanger-Quintana A; Cañedo Villarroya E; Quijada-Fraile P; Bellusci M; Chumillas Calzada S; Bergua Martínez A; Stanescu S; Martínez-Pardo Casanova M; Ruíz-Sala P; Ugarte M; Pérez González B; Pedrón-Giner C
    J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1223-1231. PubMed ID: 36112821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of methylcitrate in dried urine spots by liquid chromatography tandem mass spectrometry for the diagnosis of propionic and methylmalonic acidemias.
    Al Dhahouri N; Langhans CD; Al Hammadi Z; Okun JG; Hoffmann GF; Al-Jasmi F; Al-Dirbashi OY
    Clin Chim Acta; 2018 Dec; 487():41-45. PubMed ID: 30217751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcomes of patients with combined methylmalonic acidemia and homocystinuria after treatment].
    Huang Z; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Ji WJ; Li XY; Gu XF
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):194-8. PubMed ID: 23751581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin.
    Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS
    Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry.
    Dionisi-Vici C; Deodato F; Röschinger W; Rhead W; Wilcken B
    J Inherit Metab Dis; 2006; 29(2-3):383-9. PubMed ID: 16763906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of a second-tier test panel in dried blood spot samples using liquid chromatography-tandem mass spectrometry in Catalonia's newborn screening programme.
    Pajares-García S; González de Aledo-Castillo JM; Flores-Jiménez JE; Collado T; Pérez J; Paredes-Fuentes AJ; Argudo-Ramírez A; López-Galera RM; Prats B; García-Villoria J
    Clin Chem Lab Med; 2024 Feb; 62(3):493-505. PubMed ID: 37794778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.